Acne Medication Market Study With Prominent Key Players Like Allergan Plc., Nestle S.A. (Galderma S.A.), Johnson & Johnson, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc., GlaxoSmithKline Plc (Stiefel Laboratories, Inc.)

Acne vulgaris is a skin disease, characterized with the growth of pimples, oily skin, and blackheads. This is caused due to dead skin cells, clogged hair follicles, and oil secretion from the skin. According to various studies, it is estimated that the average age of onset of acne is 11-15 years due to changes in demographics and social habits. Several acne treatment options are developed, among which acne medications are employed in the treatment of mild to severe acne cases. These medications include topical retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and others.

Acne medication market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025, registering a CAGR of 3.9% from 2018 to 2025.

Get sample copy of this market study: https://www.alliedmarketresearch.com/request-sample/4356

Market Dynamics

Rise in patients suffering from acne vulgaris condition, especially teenagers, is the major factor that drives the growth of the global acne medication market. Other factors such as rise in demand for skin care products and unhealthy urban lifestyle are expected to have a significant impact on the growth of the market. However, factors such as side effects associated with acne drugs and presence of alternative treatment options such as laser, hamper the market growth.

The use of acne medications is the highest in North America, owing to a large patient population and high adoption of prescription-based products, and is followed by Europe and Asia-Pacific. In addition, acne medication providers and distributors are focused on expanding their presence in the emerging economies, which in turn is anticipated to drive the market growth.

Make purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4356

Top Investment in Pockets:

North America was the leading revenue contributor to the global acne medication market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of acne medication products and high adoption of prescription medicines in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 5.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward safe acne medications products.

Segment Review:

The retinoids segment accounted for the largest share in 2017, owing to high usage in treatment of acne and lesser side effects as compared to other therapeutics. However, the salicylic acid segment is expected to grow at the high CAGR from 2018 to 2025.

The inflammatory acne segment is the largest acne type segment in the global acne medication market in 2017 and is expected to maintain its lead in the forecast period. On the other hand, non-inflammatory acne segment is anticipated to record the highest CAGR from 2018-2025.

By type, the prescription medicine segment dominated the global acne treatment market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.
The utilization rate of topical medications for acne treatment is high owing to high availability of these products with high success rate and lesser side effects. However, the oral medication segment is expected to grow at a CAGR of 3.6% during the forecast period.

Access full summary of this study: https://www.alliedmarketresearch.com/acne-medication-market

Key Findings of the Acne Medication Market:

• The antibiotics segment accounted for nearly one-fourth share of the global acne medication market in 2017.

• The over-the-counter medicine segment is expected to grow at a CAGR of 2.9% from 2018 to 2025.

• The non-inflammatory acne segment accounted for around two-fifths share of the global market in 2017.

• Europe accounted for around one-fourth share of the global market in 2017.

• LAMEA is expected to provide lucrative market growth opportunities and grows with the CAGR of 4.5% from 2018 to 2025.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.